Literature DB >> 9747774

Comparisons of ELISA and Western blot assays for detection of Cryptosporidium antibody.

F J Frost1, A A de la Cruz, D M Moss, M Curry, R L Calderon.   

Abstract

A seroprevalence survey was conducted using ELISA and Western blot (WB) assays for antibody to three Cryptosporidium antigens on 380 blood donors in Jackson County, Oregon. The purpose was to determine if either assay could detect serological evidence of an outbreak which occurred in Talent, Oregon 6 months earlier. The ELISA, which tested for combined IgG, IgA and IgM, and the WB, which tested separately for IgG and IgA, detected an almost twofold increase in serological response for persons who consumed Talent drinking water during the previous 11 months. The increases, however, were statistically significant (P < 0.05) only for the WB. The identification of serological evidence of infection, using sera collected 6 months after the end of the outbreak in a population not selected because of cryptosporidiosis-like illness, suggests that assays of Cryptosporidium-specific IgG and IgA may assist in estimating the magnitude of asymptomatic infections in the population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9747774      PMCID: PMC2809493          DOI: 10.1017/s0950268898008991

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  8 in total

1.  Serological responses to Cryptosporidium infection.

Authors:  T B Muller; F J Frost; G F Craun; R L Calderon
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Quality assurance considerations in cryptosporidium antibody tests.

Authors:  Floyd Frost; Tim Muller; Twila Kunde; Gunther Craun
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

3.  Serologic response to human Cryptosporidium infections.

Authors:  F J Frost; G F Caun
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

4.  Enzyme immunoassay detection of antigen-specific immunoglobulin g antibodies in longitudinal serum samples from patients with cryptosporidiosis.

Authors:  J W Priest; A Li; M Khan; M J Arrowood; P J Lammie; C S Ong; J M Roberts; J Isaac-Renton
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

5.  Cloning and expression of a DNA sequence encoding a 41-kilodalton Cryptosporidium parvum oocyst wall protein.

Authors:  M C Jenkins; J Trout; C Murphy; J A Harp; J Higgins; W Wergin; R Fayer
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

6.  Serological evidence of Cryptosporidium infections in southern Europe.

Authors:  F J Frost; E Fea; G Gilli; F Biorci; T M Muller; G F Craun; R L Calderon
Journal:  Eur J Epidemiol       Date:  2000-04       Impact factor: 8.082

7.  Antibody response of healthy adults to recombinant thrombospondin-related adhesive protein of cryptosporidium 1 after experimental exposure to cryptosporidium oocysts.

Authors:  Pablo C Okhuysen; G Aaron Rogers; Andrea Crisanti; Furio Spano; David B Huang; Cynthia L Chappell; Saul Tzipori
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

8.  A hospital-based serological survey of cryptosporidiosis in the Republic of Korea.

Authors:  Jong-Kyu Lee; Eun-Taek Han; Sun Huh; Woo-Yoon Park; Jae-Ran Yu
Journal:  Korean J Parasitol       Date:  2009-08-28       Impact factor: 1.341

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.